Annual Drug Patent Expirations for KALYDECO
Kalydeco is a drug marketed by Vertex Pharms Inc and Vertex Pharms and is included in two NDAs. It is available from one supplier. There are eleven patents protecting this drug.
Drug patent litigation for KALYDECO.
This drug has two hundred and nine patent family members in thirty-two countries.
The generic ingredient in KALYDECO is ivacaftor. One supplier is listed for this compound. Additional details are available on the ivacaftor profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
